Les Kaplan
Director/Board Member en NICOX SA .
Perfil
Lester J.
Kaplan is currently a Director at Nicox Ophthalmics, Inc., an Independent Director at Nicox SA, a Director at Keck Graduate Institute of Applied Life Sciences, a Director at Foundation Fighting Blindness Clinical Research Institute, a Director at FFB Clinical Research Institute, and a Director at AiViva BioPharma, Inc. He was previously the Chairman of Altheos, Inc., Director & President-Research & Development at Allergan, Inc., and an Independent Director at ACADIA Pharmaceuticals, Inc. He also served as a Director at Neurotech Pharmaceuticals, Inc., Acucela, Inc., and Medinox, Inc. Kaplan holds a graduate and doctorate degree from the University of California, Los Angeles, and an undergraduate degree from the University of Illinois.
Cargos activos de Les Kaplan
| Empresas | Cargo | Inicio |
|---|---|---|
| NICOX SA | Director/Board Member | 01/10/2014 |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Director/Board Member | - |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Director/Board Member | 01/01/2014 |
| Keck Graduate Institute of Applied Life Sciences | Director/Board Member | - |
| FFB Clinical Research Institute | Director/Board Member | - |
Aiviva Biopharma, Inc.
 Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Director/Board Member | 18/09/2023 |
Antiguos cargos conocidos de Les Kaplan.
| Empresas | Cargo | Fin |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Director/Board Member | 02/11/2015 |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Chairman | 18/11/2013 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 01/04/2004 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formación de Les Kaplan.
| University of California, Los Angeles | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| NICOX SA | Health Technology |
| Empresas privadas | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Medinox, Inc.
 Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Health Technology |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Finance |
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
| FFB Clinical Research Institute | |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Les Kaplan
